CRVL

CorVel Corporation

Price

$60.36

return (12m)

-35.40%

p/e

28.24

p/bv

7.90

DIVIDEND YIELD

0.00%

CRVL price

CorVel

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRVL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.14%

3 months

7.00%

1 year

-35.40%

2 years

-78.89%

5 years

-55.67%

10 years

32.28%

Fundamentals CRVL

Valuation

P/E

28.24

Sector -2.36

Industry 0.98

P/BV

7.90

Sector 2.16

Industry 2.53

P/Revenue (PSR)

3.25

Sector 2.00

Industry 0.76

P/EBITDA

17.82

Sector -0.13

Industry 1.08

P/EBIT

21.77

Sector -2.10

Industry 3.17

P/Total Assets

4.85

Sector 1.17

Industry 0.93

EPS

2.16

Sector -0.93

Industry -0.57

BVPS

7.73

Sector 3.88

Industry 5.17

Efficiency

Gross Margin

24.29%

Sector 44.07%

Industry 30.88%

Operating Margin

14.93%

Sector -25.88%

Industry -7.64%

Net Profit Margins

11.51%

Sector -30.34%

Industry -16.97%

Profitability

ROE

27.99%

Sector -34.57%

Industry -29.67%

ROA

17.16%

Sector -28.64%

Industry -15.42%

ROIC

36.95%

Sector -441.27%

Industry -111.79%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Debt

Equity/Assets

0.61

Sector 0.43

Industry 0.26

Liabilities/Assets

0.39

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

9.09%

Sector -

Industry -

5Y Earnings CAGR

12.37%

Sector -

Industry -

FAIR VALUE OF CorVel ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$60.36

Fair Value

$19.38

Upside Return potential.

-67.89%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CRVL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
CRVL	28.24	7.90	27.99%	0.00%	$3.12 B	11.51%
CI	11.58	1.78	15.39%	2.16%	$75.20 B	2.34%
UHS	6.06	1.21	20.00%	0.53%	$9.22 B	8.56%
DGX	22.66	3.00	13.22%	1.55%	$23.20 B	9.08%
STRRP	8.16	2.56	31.31%	9.43%	$163.57 M	25.96%
ENSG	27.54	4.22	15.33%	0.15%	$10.01 B	6.89%
JYNT	38.39	8.03	20.92%	0.00%	$124.39 M	5.72%
OPCH	16.48	2.51	15.26%	0.00%	$3.40 B	3.64%
MGLN	8.00	1.53	19.13%	0.00%	$2.42 B	6.38%
PGNY	37.63	5.80	15.40%	0.00%	$2.55 B	5.23%
VAR	58.58	7.26	12.40%	0.00%	$16.26 B	5.85%
PNTG	48.21	3.75	7.79%	0.00%	$1.46 B	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRVL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CorVel

CorVel Corporation

Average Investor10 user rating

4.0 (2 people)

United States

39 years

Founded: 1987

1991

Time since IPO - 35 years

3.681

Employees

CorVel Corporation (United States) is listed on the Nasdaq and has a market capitalization of $3.12 billion, with shareholders equity totaling $394.23 million.

The company employs approximately 3.681 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, CorVel Corporation reported $958.52 million in revenue, generating net income of $110.34 million.

Key financial metrics include a P/E ratio of 28.24, a price-to-book (P/B) ratio of 7.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRVL.

Market cap

$3.12 billion

Net worth

$394.23 million

$394,230,000.00

Assets

$642.99 million

$642,990,000.00

Total Shares Outstanding

51.00 million

51,000,000

Average Daily Trading Volume

$222.50 Thousand

$222,498.00

Sector

Health

Industry

Health Establishments

CRVL

CRVL revenue and profits

Financial Results CRVL

DRAG THE FRAME TO SEE MORE DATA

CRVL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$109.45 85,17% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$287.16 --0,45% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$67.22 145,04% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$407.13 85,54% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.80 --5,01% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,163.75 51,17% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$371.79 2,66% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$154.86 38,31% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56